Expression of coxsackie and adenovirus receptor is correlated with inferior prognosis in liver cancer patients
Authors:
Open Access
- 24 December 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 17 (2) , 2485-2490
Abstract
The coxsackie and adenovirus receptor (CAR), a tumor suppressor, is vital for the effectiveness of therapies which utilize the adenovirus. However, studies on CAR expression in hepatocellular carcinoma (HCC) are conflicting and its clinical significance requires exploration. In this study, immunohistochemistry has been carried out on tissue microarrays consisting of 198 pairs of HCC and neighboring healthy tissue specimens from Chinese Han patients to evaluate CAR expression. Relative to normal tissues, decreased CAR expression (56% vs. 57%; P<0.001) was detected in HCC samples. CAR immunopositivity in tumors was not dependent upon sex, age, tumor dimensions, differentiation, TNM stage or metastasis in HCC patients; however, positive expression was observed in 56% of the samples from patients with hepatic metastasis, which was the same as those devoid of metastasis (56%; P=0.042). Furthermore, survival analysis confirmed that the expression of CAR revealed no correlation with the prognosis. It was established that CAR exerted complex effects during liver tumorigenesis, potentially based on the stage of the cancer. Therefore, CAR expression analysis has to be carried out prior to adenoviral oncolytic therapy to stratify the patients.Keywords
This publication has 37 references indexed in Scilit:
- Oncolytic viruses as therapeutic cancer vaccinesMolecular Cancer, 2013
- Dendritic Cells in the Cancer MicroenvironmentJournal of Cancer, 2013
- Impact of the coxsackievirus and adenovirus receptor on the adenoma–carcinoma sequence of colon cancerBritish Journal of Cancer, 2011
- Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progressionBritish Journal of Cancer, 2009
- Coxsackievirus and adenovirus receptor expression in human endometrial adenocarcinoma: possible clinical implicationsWorld Journal of Surgical Oncology, 2008
- Soluble isoforms but not the transmembrane form of coxsackie‐adenovirus receptor are of clinical relevance in epithelial ovarian cancerInternational Journal of Cancer, 2007
- Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A regionCancer Gene Therapy, 2005
- Erratum: Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class 1 expression in human prostate cancer cell lines: implications for gene therapy strategiesProstate Cancer and Prostatic Diseases, 2003
- Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategiesProstate Cancer and Prostatic Diseases, 2003
- Adenovirus Fiber Disrupts CAR-Mediated Intercellular Adhesion Allowing Virus EscapeCell, 2002